Used in the evaluation of canine conjunctivitis to diagnose tear deficiency as a contributing factor to ocular surface diseases and to assess lacrimal gland function.
LEARN MOREGilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREAn aid in the prevention of pneumonia, diarrhea, septicemia and mortality caused by Salmonella Choleraesuis and as an aid in control of disease caused by…
LEARN MORE